(原标题:授权合作提前“预喜”,石药集团为何这么急?)作者 | 武月来源 | 氨基观察导语:提前“预告”3项各50亿美元的交易,即使首付款按照5%计算,也高达7.5亿美元。这对于石药集团短期内的业绩提升不言而喻。所有人的目光都集中在石药集团的BD“预喜”公告上。5月30日上午,石药集团发布一份潜在授权即合作的公告,简单来说,包括EGFR ADC在内的多款产品正在磋商BD,共涉及3项潜在交易;每笔...
Source Link(原标题:授权合作提前“预喜”,石药集团为何这么急?)作者 | 武月来源 | 氨基观察导语:提前“预告”3项各50亿美元的交易,即使首付款按照5%计算,也高达7.5亿美元。这对于石药集团短期内的业绩提升不言而喻。所有人的目光都集中在石药集团的BD“预喜”公告上。5月30日上午,石药集团发布一份潜在授权即合作的公告,简单来说,包括EGFR ADC在内的多款产品正在磋商BD,共涉及3项潜在交易;每笔...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.